Demographics | Number (%) of cases |
---|---|
Gender (n = 53) | |
Male | 37 (69.8) |
Female | 16 (30.2) |
Age (n = 53) | |
0–18 | 9 (17) |
19–64 | 28 (52.8) |
≥ 65 | 16 (30.2) |
median age | 52 |
Comorbidities (n = 53) | |
high blood pressure | 12 (22.6) |
cancer | 10 (18.9) |
diabetes mellitus | 8 (15.1) |
obesity | 6 (11.3) |
ischemic heart disease | 5 (9.4) |
chronic obstructive pulmonary disease | 5 (9.4) |
liver cirrhosis | 2 (3.8) |
Hospital ward (n = 53) | |
medical | 27 (50.9) |
ICU | 19 (35.9) |
surgical | 5 (9.4) |
other | 2 (3.8) |
medical evacuation | 25 (47.2) |
Isolate site (n = 67)a | |
rectal swab / stool | 49 (73.1) |
urine | 9 (13.4) |
blood | 4 (6) |
sputum | 3 (4.5) |
skin / soft tissue | 2 (3) |
Exposure to carbapenems (n = 51) | |
imipenem | 9 (17.6) |
meropenem | 3 (5.9) |
no exposure | 39 (76.5) |
Infections / Colonizations (n = 53) | |
infection | 8 (15.1) |
colonization | 45 (84.9) |
Cross-transmission (n = 53) | |
yes | 7 (13.2) |
no | 46 (86.8) |